Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

SHE:002082 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	158.73	226.61	467.62	912.02	574.18
Cash & Short-Term Investments	158.73	226.61	467.62	912.02	574.18
Cash Growth	-29.95%	-51.54%	-48.73%	58.84%	-26.55%
Accounts Receivable	1,033	1,157	1,263	1,157	1,311
Other Receivables	18.57	58.67	57.15	20.54	41
Receivables	1,051	1,216	1,320	1,178	1,352
Inventory	213.86	255.91	283.15	261.41	850.89
Prepaid Expenses	-	3.31	4.46	4.13	-
Other Current Assets	379.51	221.63	125.34	113.66	305.29
Total Current Assets	1,803	1,923	2,201	2,469	3,082
Property, Plant & Equipment	1,564	1,495	1,274	1,175	1,739
Long-Term Investments	112.08	10.52	12.35	12.91	15.3
Goodwill	125.67	125.46	127.93	194.79	217.87
Other Intangible Assets	461.79	418.46	430.97	398.65	491.68
Long-Term Accounts Receivable	-	12.79	6.57	3.97	5.88
Long-Term Deferred Tax Assets	134.44	113.62	90.54	54.23	47.02
Long-Term Deferred Charges	63.04	58.5	30.2	23.52	19.89
Other Long-Term Assets	62.97	138.69	44.47	39.06	44
Total Assets	4,327	4,296	4,218	4,371	5,662
Accounts Payable	247.36	302.55	231.18	254.51	355.61
Accrued Expenses	29.78	73.08	63.79	95.99	132.8
Short-Term Debt	853.97	825.43	677.96	572.21	1,116
Current Portion of Long-Term Debt	57.43	54.27	37.28	31.5	12.11
Current Portion of Leases	-	2.65	0.55	0.54	-
Current Income Taxes Payable	51.9	17.34	24.6	190.25	49.29
Current Unearned Revenue	16.82	14.31	30.28	33.21	75.65
Other Current Liabilities	59.02	36.98	71.61	105.19	123.33
Total Current Liabilities	1,316	1,327	1,137	1,283	1,865
Long-Term Debt	104	81.51	135.2	237	746.8
Long-Term Leases	11.61	11.99	13.43	1.22	-
Long-Term Unearned Revenue	92.18	70.54	68.06	59.37	102.52
Long-Term Deferred Tax Liabilities	44.21	40.83	39.36	33.5	31.07
Other Long-Term Liabilities	2.68	5.91	6.48	12.19	58.75
Total Liabilities	1,571	1,537	1,400	1,627	2,804
Common Stock	616.69	616.69	618.22	618.22	618.22
Additional Paid-In Capital	311.78	311.78	305.79	305.79	320.08
Retained Earnings	1,827	1,820	1,844	1,751	1,708
Treasury Stock	-59.99	-59.99	-59.99	-50.96	-
Comprehensive Income & Other	-28.34	-30.92	-21	-25.88	-24.21
Total Common Equity	2,667	2,658	2,687	2,598	2,622
Minority Interest	89.64	101.28	131.02	146.33	236.47
Shareholders' Equity	2,756	2,759	2,818	2,745	2,858
Total Liabilities & Equity	4,327	4,296	4,218	4,371	5,662
Total Debt	1,027	975.84	864.42	842.48	1,875
Net Cash (Debt)	-868.29	-749.23	-396.8	69.54	-1,301
Net Cash Per Share	-1.41	-1.22	-0.64	0.11	-2.15
Filing Date Shares Outstanding	613.6	611.69	613.22	614.08	618.22
Total Common Shares Outstanding	613.6	611.69	613.22	614.08	618.22
Working Capital	487.05	596.66	1,064	1,185	1,217
Book Value Per Share	4.35	4.34	4.38	4.23	4.24
Tangible Book Value	2,079	2,114	2,128	2,005	1,912
Tangible Book Value Per Share	3.39	3.46	3.47	3.26	3.09
Buildings	-	700.33	577.02	530.22	381.11
Machinery	-	703.7	679.8	668.65	1,226
Construction In Progress	-	611.33	472.39	380.88	1,043

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.